Studies on the pharmaceutical potentiation of drugs. I. p-Aminosalicylic acid derivatives.
1967
K Kakemi, and
T Arita, and
S Kitazawa, and
M Kawamura, and
H Takenaka
UI
MeSH Term
Description
Entries
D009169
Mycobacterium tuberculosis
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
Mycobacterium tuberculosis H37Rv
D011485
Protein Binding
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
Plasma Protein Binding Capacity,Binding, Protein
D004357
Drug Synergism
The action of a drug in promoting or enhancing the effectiveness of another drug.
Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000636
Aminosalicylic Acids
A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.
Acids, Aminosalicylic
Related Publications
K Kakemi, and
T Arita, and
S Kitazawa, and
M Kawamura, and
H Takenaka